Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
Abstract
Adipose derived regenerative cells are used to treat patients, including patients with cardiovascular conditions, diseases or disorders. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of regenerative cells, e.g., stem and/or progenitor cells, obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the stem cells are not exposed to an external environment prior to being administered to a patient. Accordingly, in a preferred method, adipose derived regenerative cells are placed directly into a recipient along with such additives necessary to promote, engender or support a therapeutic cardiovascular benefit.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for treating a disorder characterized by insufficient cardiac function in a subject, comprising administering to the subject a composition comprising adipose derived cells, such that the disorder is treated.Join the waitlist — get patent alerts
Track US2017281771A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.